DreamFields Brands Faces Lawsuit Saying Weed Isn’t Strong Enough


A California marijuana company is being sued for false advertising after two disgruntled customers said its weed wasn’t strong enough.

The class action lawsuit was filed in Los Angeles County Superior Court against DreamFields Brands, Inc. for allegedly falsely claiming that their products had high THC content, according to the lawsuit.

THC, or tetrahydrocannabinol, is the compound in marijuana that makes users feel high.

Jasper Centeno of Long Beach and Blake Wilson of Fresno, filed the 26-page lawsuit Oct. 20 over additional allegations including unfair competition and negligent misrepresentation.

Both complainants claim to have purchased pre-rolled Jeeter brand joints that were advertised as having a high THC content.

As required by California Department of Cannabis Control regulations, all Jeeter products claim to have a specific high THC content, plaintiffs’ attorney Christin Cho wrote in the lawsuit.

“Because cannabis consumers generally prefer and are willing to pay more for high-THC cannabis products, declaring that their products have a very high THC content allows defendants to charge higher rates for their products. cannabis products,” the lawsuit states.

But testing, the suit continues, found the joints actually had a lower THC content than advertised, meaning “millions of consumers” were paying too much for a lower product.

New owner of Miss Universe:Thai transgender businesswoman buys Miss Universe for $20 million

Jeeter, a subsidiary of DreamFields – the company that produced the seals – could not immediately be reached for comment on USA TODAY.

But in a statement shared with CNN, the Desert Hot Springs-based company called the allegations “baseless and ridiculous.”

“Allegations about our THC levels are false,” the statement read. “We are proud of our compliance and commitment to state-mandated testing procedures, including independent third-party testing. The product and our integrity (is) something we truly value as a business, and take all appropriate and legal action before our product hits the shelves.

Blood pressure medication reminder:Some Pills Pose Potential Cancer Risk, FDA Says

The plaintiffs seek damages, including restitution, an injunction against the company as well as attorneys’ fees in the case.

Natalie Neysa Alund covers trending news for USA TODAY. Contact her at nalund@usatoday.com and follow her on Twitter @nataliealund.

[ad_2]Source link

About Alex S. Crone

Check Also

Analysts at Truist Financial have cut their price target for BellRing Brands (NYSE: BRBR) to $25.00.

[ad_1] Research analysts at Truist Financial lowered their price target for BellRing Brands (NYSE:BRBR) from …